decisionhealth Newsletters, Answer Books - 2009 Issue 3 (March)
Fraud Alerts / OIG Special Fraud Alerts / Special Fraud Alert_October 1994 / Background
Subscribe or sign in to view the full article.
Article Overview
This article explains the background for an OIG Special Fraud Alert focused on clinical laboratory arrangements and referral relationships. It discusses why these relationships matter to Medicare and Medicaid, how the OIG views items or services of value exchanged between laboratories and referral sources, and the general compliance concerns that can arise in this setting. The piece is relevant to physicians, clinical laboratories, compliance staff, and coding or billing professionals who need to understand the scope of the fraud alert.
Why This Topic Matters
Clinical laboratory referral arrangements can create fraud and abuse risk when value is exchanged outside fair market value expectations. Understanding the OIG’s background concerns helps organizations recognize when a lab relationship may need closer compliance review.
What You Will Learn
- Why clinical laboratory referral relationships draw OIG scrutiny
- How the OIG frames value exchanged between laboratories and referral sources
- The general compliance context for Anti-Kickback Statute concerns involving labs
- Why these arrangements matter for Medicare and Medicaid programs
Who Should Read This
- Physicians
- Clinical laboratories
- Compliance officers
- Medical billing professionals
- Healthcare administrators
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com